Immune responses in COVID-19 and tuberculosis coinfection: A scoping review
K Flores-Lovon, B Ortiz-Saavedra… - Frontiers in …, 2022 - frontiersin.org
Background and aim Patients with COVID-19 and tuberculosis coinfection are at an
increased risk of severe disease and death. We therefore sought to evaluate the current …
increased risk of severe disease and death. We therefore sought to evaluate the current …
[HTML][HTML] Association of triglyceride-glucose index with prognosis of COVID-19: A population-based study
Y Chang, J Jeon, TJ Song, J Kim - Journal of Infection and Public Health, 2022 - Elsevier
Abstract Background Triglyceride-glucose (TyG) index is a simple and reliable surrogate
marker for insulin resistance. Epidemiology studies have shown that insulin resistance is a …
marker for insulin resistance. Epidemiology studies have shown that insulin resistance is a …
[HTML][HTML] Clinical profile, treatment, and outcomes of patients with COVID-19 in a tertiary referral hospital in South Sumatera, Indonesia: A retrospective single-center …
D Marteka, A Malik, I Faustine… - Belitung nursing journal, 2022 - ncbi.nlm.nih.gov
Background Although there are fewer COVID-19 cases in Indonesia, the pandemic is still
ongoing. COVID-19 has a significant death rate in Indonesia, but lack of information on the …
ongoing. COVID-19 has a significant death rate in Indonesia, but lack of information on the …
Deciphering SARS CoV-2-associated pathways from RNA sequencing data of COVID-19-infected A549 cells and potential therapeutics using in silico methods
Background: Coronavirus (CoV) disease (COVID-19) identified in Wuhan, China, in 2019, is
mainly characterized by atypical pneumonia and severe acute respiratory syndrome (SARS) …
mainly characterized by atypical pneumonia and severe acute respiratory syndrome (SARS) …
Hematological changes as a consequence of COVID-19 and its vaccines
JC Vizcaíno-Carruyo, AI Toro-Montoya - Medicina & Laboratorio, 2022 - medigraphic.com
The SARS-CoV-2 virus continues to infect millions of individuals around the world. Although
the most frequent symptoms observed in patients with COVID-19 are fever, fatigue and …
the most frequent symptoms observed in patients with COVID-19 are fever, fatigue and …
Efficacy and Safety of Andrographolide and Favipiravir Versus Favipiravir Monotherapy in Patients with Mild COVID-19 Infection: A Multicenter Randomized Controlled …
T Prasoppokakorn, S Sriphoosanaphan… - OBM Integrative and …, 2024 - lidsen.com
Reports indicate that Andrographolide inhibits viral replication and reduces COVID-19
symptoms. This study aimed to determine Andrographolide's additional effect and safety in …
symptoms. This study aimed to determine Andrographolide's additional effect and safety in …
[PDF][PDF] КОВІД-19-АСОЦІЙОВАНІ ЗМІНИ ІМУНИТЕТУ ТА УРАЖЕННЯ ЛЕГЕНЬ
ОМ Рекалова - 2023 - ifp.kiev.ua
Резюме В огляді літератури представлено основні дані про механізми патогенезу нової
вірусної інфекції Ковід-19: вірусного ураження, імунної дисфункції, ендотеліального …
вірусної інфекції Ковід-19: вірусного ураження, імунної дисфункції, ендотеліального …
Alteraciones hematológicas como consecuencia de COVID-19 y sus vacunas
JCV Carruyo, AIT Montoya - Medicina & Laboratorio, 2022 - dialnet.unirioja.es
El virus SARS-CoV-2 continúa infectando a millones de individuos en el mundo. Aunque los
síntomas más frecuentes observados en los pacientes con COVID-19 son fiebre, fatiga y tos …
síntomas más frecuentes observados en los pacientes con COVID-19 son fiebre, fatiga y tos …
Efficacy of intravenous immunoglobulin in the treatment of a COVID-19 patient
M Stojanović, M Marković, D Đinović… - Srpski arhiv za …, 2022 - doiserbia.nb.rs
Introduction. Diabetes mellitus patients are a vulnerable group of people who are prone to
getting infected with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). The …
getting infected with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). The …
[PDF][PDF] Case report/Приказ болесника
D Stojanović, M Marković, D Đinović, S Popović… - 2017 - srpskiarhiv.rs
Introduction Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor
that occurs in the gastrointestinal tract, most commonly in the stomach or small intestine. The …
that occurs in the gastrointestinal tract, most commonly in the stomach or small intestine. The …